CY1308A - Device for dispensing medicaments - Google Patents

Device for dispensing medicaments

Info

Publication number
CY1308A
CY1308A CY130880A CY130880A CY1308A CY 1308 A CY1308 A CY 1308A CY 130880 A CY130880 A CY 130880A CY 130880 A CY130880 A CY 130880A CY 1308 A CY1308 A CY 1308A
Authority
CY
Cyprus
Prior art keywords
dispensing medicaments
medicaments
dispensing
Prior art date
Application number
CY130880A
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CY1308A publication Critical patent/CY1308A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
CY130880A 1979-12-06 1980-12-05 Device for dispensing medicaments CY1308A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7942208 1979-12-06
GB8039174A GB2064336B (en) 1979-12-06 1980-12-05 Device for dispensing medicaments

Publications (1)

Publication Number Publication Date
CY1308A true CY1308A (en) 1985-12-06

Family

ID=26273811

Family Applications (1)

Application Number Title Priority Date Filing Date
CY130880A CY1308A (en) 1979-12-06 1980-12-05 Device for dispensing medicaments

Country Status (2)

Country Link
CY (1) CY1308A (en)
GB (1) GB2064336B (en)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570013B2 (en) * 1982-10-08 1988-03-03 Glaxo Group Limited Medicament inhaler
JPS63143081A (en) * 1986-12-05 1988-06-15 メクト株式会社 Inhalator
GB9021433D0 (en) * 1990-10-02 1990-11-14 Atomic Energy Authority Uk Power inhaler
GB2253200A (en) * 1991-02-01 1992-09-02 Harris Pharma Ltd Inhalation apparatus and fracturable capsule for use therewith
GB9216038D0 (en) * 1992-07-28 1992-09-09 Bespak Plc Dispensing apparatus for powdered medicaments
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
DE19835346A1 (en) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Two-part capsule for pharmaceutical preparations for powder inhalers
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
IL154175A0 (en) 2000-08-05 2003-07-31 Glaxo Group Ltd 17. beta.-carbothioate 17. alpha-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
EP1238680B1 (en) * 2001-03-05 2003-12-10 Ivo Pera Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
WO2002076933A1 (en) 2001-03-22 2002-10-03 Glaxo Group Limited Formailide derivatives as beta2-adrenoreceptor agonists
AU2002253342B2 (en) 2001-04-30 2007-01-04 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
CA2458534C (en) 2001-09-14 2011-11-01 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
WO2003024396A2 (en) 2001-09-17 2003-03-27 Glaxo Group Limited Dry powder medicament formulations
ATE381535T1 (en) 2002-04-25 2008-01-15 Glaxo Group Ltd PHENETHANOLAMINE DERIVATIVES
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
PT1556342E (en) 2002-10-28 2008-04-28 Glaxo Group Ltd Phenethanolamine derivative for the treatment of respiratory diseases
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
PE20050250A1 (en) 2003-07-17 2005-04-08 Glaxo Group Ltd ANTAGONISTS OF ACETYLCHOLIN MUSCARINAL RECEPTORS
TW200811172A (en) 2003-10-14 2008-03-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US7507747B2 (en) 2003-10-17 2009-03-24 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
AR046225A1 (en) 2003-11-04 2005-11-30 Glaxo Group Ltd COMPOSITE OF 8-AZONIABICICLO (3.2.1) OCTOBER, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES MEDIATED BY MUSCARINIC ACETILCOLINE RECEPTORS THAT UNDERSTAND IT AND USE OF THE COMPOUND TO PREPARE SUCH COMPOSITION
DE10352277A1 (en) 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
GB0329182D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
JP2007529513A (en) 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド M3 muscarinic acetylcholine receptor antagonist
JP2007530652A (en) 2004-04-02 2007-11-01 グラクソ　グループ　リミテッド Chemical substances, preparation methods and new crystalline forms
UY28871A1 (en) 2004-04-27 2005-11-30 Glaxo Group Ltd ANTAGONISTS OF THE MUSCARINIC ACETILCOLINE RECEIVER
JP2007537261A (en) 2004-05-13 2007-12-20 グラクソ　グループ　リミテッド Muscarinic acetylcholine receptor antagonist
US7556035B2 (en) 2004-05-28 2009-07-07 Quadrant Technologies Limited Unit dose dry powder inhaler
DE102005001332A1 (en) 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Two-piece capsule with pre-closure for holding pharmaceutical preparations for powder inhalers
KR20070119631A (en) 2005-02-10 2007-12-20 글락소 그룹 리미티드 Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
PE20061351A1 (en) 2005-03-25 2007-01-14 Glaxo Group Ltd 8H-PYRID [2,3-d] PYRIMIDIN-7-ONA 2,4,8-TRISUSTITUTED COMPOUNDS AS CSBP / RK / p38 KINASE INHIBITORS
TW200724142A (en) 2005-03-25 2007-07-01 Glaxo Group Ltd Novel compounds
EP1937068A4 (en) 2005-08-18 2010-08-04 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
PT103481B (en) 2006-05-16 2008-08-01 Hovione Farmaciencia S A INHALER OF SIMPLE USE AND INHALATION METHOD
AR065804A1 (en) 2007-03-23 2009-07-01 Smithkline Beecham Corp COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
GB2463451A (en) 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
DK2400950T3 (en) 2009-02-26 2019-07-29 Glaxo Group Ltd PHARMACEUTICAL FORMULA comprising 4 - {(1 R) -2 - [(6- {2 - [(2,6-DICHLORBENZYL) OXY] ETHOXY} HEXYL) AMINO] -1-HYDROXYETHYL} -2- (HYDROXYMETHYL) PHENOL
TW201111392A (en) 2009-06-16 2011-04-01 Schering Corp Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
ES2546422T5 (en) 2010-08-31 2023-01-20 Glaxosmithkline Ip Dev Ltd Dry powder inhalation medicinal products having moisture control properties and methods of administration thereof
ES2705494T3 (en) 2010-08-31 2019-03-25 Glaxosmithkline Ip Dev Ltd Pharmacological products for the inhalation of dry powder that have humidity control properties and methods of administration thereof
WO2012064286A1 (en) 2010-11-11 2012-05-18 Agency For Science, Technology And Research Targeting metabolic enzymes in human cancer
GB201116641D0 (en) 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
CA2871534A1 (en) 2012-04-27 2013-10-31 Glaxo Group Limited Novel compounds
GB201207406D0 (en) 2012-04-27 2012-06-13 Glaxo Group Ltd Novel compounds
SG11201503697TA (en) 2012-11-28 2015-06-29 Intercept Pharmaceuticals Inc Treatment of pulmonary disease
CN107428828A (en) 2015-03-11 2017-12-01 葛兰素史密斯克莱知识产权发展有限公司 TSLP associated proteins
CA2988373A1 (en) 2015-06-15 2016-12-22 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulators
MA52309A (en) 2015-06-15 2021-02-24 Astex Therapeutics Ltd NRF2 REGULATORS
EP3766878B1 (en) 2015-06-15 2022-03-16 GlaxoSmithKline Intellectual Property Development Limited Nrf2 regulators
UY36851A (en) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS
WO2017060855A1 (en) 2015-10-06 2017-04-13 Glaxosmithkline Intellectual Property Development Limited Arylcyclohexyl pyrazoles as nrf2 regulators
WO2017060854A1 (en) 2015-10-06 2017-04-13 Glaxosmithkline Intellectual Property Development Limited Biaryl pyrazoles as nrf2 regulators
TW201825458A (en) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產（第二）有限公司 TRPV 4 antagonists
US10590077B2 (en) 2016-09-20 2020-03-17 Glaxosmithkline Intellectual Property Development Limited TRPV4 antagonists
EP3515888B1 (en) 2016-09-20 2021-03-31 GlaxoSmithKline Intellectual Property (No. 2) Limited Trpv4 antagonists
CN108779108A (en) 2016-12-06 2018-11-09 葛兰素史密斯克莱知识产权发展有限公司 3- (2,3- dihydro -1H- indenes -5- bases) propanoic derivatives and their purposes as NRF2 conditioning agents
JP2020500919A (en) 2016-12-12 2020-01-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Pyrrole 3-carboxylate as NRF2 regulator
US20200071310A1 (en) 2016-12-12 2020-03-05 Glaxosmithkline Intellectual Property Development Limited N-aryl pyrazoles as nrf2 regulators
US20220002272A1 (en) 2016-12-14 2022-01-06 Glaxosmithkline Intellectual Property Development Limited Bisaryl lactams as nrf2 activators
EP3555078B1 (en) 2016-12-14 2024-03-27 GlaxoSmithKline Intellectual Property Development Limited Bisaryl heterocycles as nrf2 activators
WO2018109647A1 (en) 2016-12-14 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Bisaryl amides as nrf2 regulators
RU2019121673A (en) 2016-12-15 2021-01-15 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед NRF2 ACTIVATORS
WO2018109649A1 (en) 2016-12-15 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Ether linked triazoles as nrf2 regulators
TWI778052B (en) 2017-04-24 2022-09-21 美商共結晶製藥公司 Inhibitors of influenza virus replication
JP2021505636A (en) 2017-12-11 2021-02-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ NRF2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ failure syndrome
WO2019116231A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
AR114082A1 (en) 2018-01-17 2020-07-22 Glaxosmithkline Ip Dev Ltd PI4KIIIb INHIBITORS
WO2019224667A1 (en) 2018-05-23 2019-11-28 Glaxosmithkline Intellectual Property Development Limited Indanes as nrf2 activators
CN112638477B (en) 2018-07-27 2024-01-26 共晶制药公司 Pyrrolo [2,3-B ] pyridine derivatives as inhibitors of influenza virus replication
CN113286793B (en) 2018-09-10 2024-04-05 共结晶制药公司 Inhibitors of influenza virus replication of pyrrolopyrazines and pyridotriazines
AU2019361038A1 (en) 2018-10-17 2021-05-13 Cocrystal Pharma, Inc. Combinations of inhibitors of influenza virus replication
WO2020102270A1 (en) 2018-11-13 2020-05-22 Cocrystal Pharma, Inc. Formulations of influenza therapeutics
WO2020112716A1 (en) 2018-11-26 2020-06-04 Cocrystal Pharma, Inc. Inhibitors of influenza virus replication
GB201908536D0 (en) 2019-06-13 2019-07-31 Glaxosmithkline Ip Dev Ltd Compounds
US20230151034A1 (en) 2020-03-17 2023-05-18 Cocrystal Pharma, Inc. Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
CA3179697A1 (en) 2020-04-10 2021-10-14 Cocrystal Pharma, Inc. Inhibitors of norovirus and coronavirus replication
WO2021216547A1 (en) 2020-04-20 2021-10-28 Sorrento Therapeutics, Inc. Pulmonary administration of ace2 polypeptides
WO2022175425A1 (en) 2021-02-22 2022-08-25 Glaxosmithkline Intellectual Property Development Limited Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
WO2022179967A1 (en) 2021-02-23 2022-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Vadadustat for treating covid-19 in a hospitalized subject
WO2023014758A1 (en) 2021-08-03 2023-02-09 Cocrystal Pharma, Inc. Inhibitors for coronaviruses

Also Published As

Publication number Publication date
GB2064336A (en) 1981-06-17
GB2064336B (en) 1984-03-14

Similar Documents

Publication Publication Date Title
GB2064336B (en) Device for dispensing medicaments
PH17193A (en) Device for dispensing medicaments
GB2062771B (en) Dispensing device
MY8500365A (en) Device for dispensing medicaments
ZA77686B (en) Device for dispensing medicaments
DE3068795D1 (en) Dispensing device for articles
NZ192628A (en) Vapour dispensing device
IL56482A (en) Tablet dispensing device
GB2124497B (en) Fluid dispensing device
GB2061169B (en) Dispenser apparatus for attachment members
JPS5640151A (en) Coating device for tablet
GB2060586B (en) Dispensing apparatus for components
GB1540999A (en) Device for dispensing feed
ZA782139B (en) Device for dispensing medicaments
DE3065187D1 (en) Self aligning aerosol dispensing device
GB2054056B (en) Fluid dispensing device
GB2042340B (en) Vapour dispensing devices
GB2039847B (en) Dispensing device
AU6478780A (en) Dispensing device
GB2066213B (en) Dispensing apparatus
ZA804779B (en) Dispensing apparatus
JPS55125868A (en) Device for carrying solid medicine
JPS55125869A (en) Device for carrying solid medicine
JPS55125888A (en) Distributing device
ZA78544B (en) Device for dispensing medicaments